The Study (and the Problem It Exposes)
What the research was actually asking
Your bloating comes back every week. Your skin flares for no obvious reason. Your GP ran the standard panel and everything came back normal — but you know something is off. A growing number of adults are turning to food sensitivity tests to find answers, but a closer look at the clinical evidence reveals a troubling gap between what these tests promise and what they can actually prove.
The question researchers have been asking is not just “do these tests work?” but something more specific and more uncomfortable: are they measuring anything that reliably connects to your symptoms at all? A PMC review examining blood testing for food sensitivity, allergy, and intolerance used fictional clinical cases — ordinary people with ordinary symptoms seeking answers — to map out exactly what the evidence behind these tests actually supports. What it found should change how you think about the next test you consider buying.
What it found about diagnostic accuracy across test types
The picture that emerged was not encouraging. Across the landscape of available tests, only a narrow category has been validated with anything approaching clinical rigour — and even those validated tests have measurable limitations. A systematic review with meta-analyses specifically assessing the diagnostic accuracy of tests for immune-mediated food allergy confirmed that even in the most researched category, false positives remain a known and documented problem. For the most widely sold consumer tests, the evidence base is not limited — it is essentially absent.
Three Different Problems, Three Different Mechanisms
True food allergy — an immune alarm that fires fast
Think of your immune system as a security team at a building. A true food allergy is like a guard who pulls the fire alarm the moment a specific person walks through the door — fast, loud, and potentially dangerous. The mechanism here involves immunoglobulin E (IgE), a type of antibody your immune system produces in response to a specific food protein. When that protein appears again, IgE triggers an immediate release of histamine and other chemicals. Symptoms arrive within minutes: hives, swelling, in severe cases anaphylaxis. This is unambiguous, reproducible, and immune-mediated in the most direct sense.
Food intolerance — a digestion problem, not an immune problem
Food intolerance is more like a faulty air conditioning unit that makes you feel awful in a particular room — unpleasant, but not a security threat. Lactose intolerance is the clearest example: your body lacks sufficient lactase enzyme to break down milk sugar properly, and the result is bloating, cramping, and digestive distress. No immune alarm. No antibody response. Just a metabolic mismatch between what you ate and what your gut can process. A narrative review confirmed that immune-mediated food allergies and non-immune adverse food reactions have distinct pathophysiologic mechanisms, clinical features, symptoms, complications, and appropriate treatments — meaning the diagnostic approach that works for one is simply irrelevant to the other.
Food sensitivity — the contested middle ground
Then there is the contested territory in the middle: food sensitivity, a term used loosely to describe delayed, diffuse reactions that do not fit neatly into either category above. This is the space that commercial food sensitivity panels claim to map. And this is where the evidence becomes thin very quickly. A review distinguishing food allergy from food intolerance confirmed that these conditions are not clinically interchangeable — and that the treatment pathway changes entirely depending on which mechanism is actually driving the reaction. Getting the category wrong means getting the solution wrong.
The Test You Are Probably Buying vs the Test That Is Actually Validated
IgE testing — what it measures and where it falls short
IgE-based testing — either through a skin prick test or a serum blood test — is the validated standard for identifying true food allergies. It measures whether your immune system has produced IgE antibodies against specific food proteins, which is directly relevant to the allergy mechanism. But even here, the picture is not clean. A positive IgE result means your immune system has been sensitised to a protein, not necessarily that eating that food will trigger a reaction. The gap between sensitisation and clinical allergy is real, and it produces false positives that can lead to unnecessary food elimination.
IgG testing — why the clinical consensus is deeply sceptical
This is the test most people are actually buying. IgG food sensitivity panels measure immunoglobulin G antibodies against a broad list of foods — sometimes 100 or more items — and return a report colour-coded by “reactivity.” The problem is that the clinical evidence base for IgG testing as a diagnostic tool for food reactions is not just limited — it is actively contradicted by what we know about how IgG antibodies function. IgG is a normal immune response to food exposure. It rises when you eat something regularly. Returning a list of high-IgG foods is, in effect, returning a list of foods you have eaten recently — not a map of foods that are making you sick. The security team, to return to the analogy, gets nervous about almost everyone on a busy day. The report tells you who was in the building. It cannot tell you who caused the incident.
Component-resolved diagnostics — the more precise option most GPs don’t offer
Component-resolved diagnostic (CRD) testing represents a genuinely more advanced approach. Rather than testing your immune response to a whole food extract — say, “peanut” — CRD testing identifies your IgE response to specific protein components within that food. This matters because different protein components carry different clinical risk profiles. A systematic review examined CRD testing’s accuracy, risk impact, and cost-effectiveness and found it provides meaningful improvements in diagnostic precision compared to standard panels. Most GP referral pathways do not offer this as a first step — which means patients who would benefit from it rarely know it exists.
The Gold Standard Nobody Uses
Why the double-blind food challenge is considered definitive
If you want certainty about whether a specific food is causing your symptoms, there is one method that consistently produces it: the double-blind, placebo-controlled food challenge (DBPCFC). In this procedure, neither you nor the clinician knows whether you are consuming the suspected food or a matched placebo. Your symptoms are recorded under controlled conditions. Because neither party knows what was consumed, the results cannot be influenced by expectation or anxiety. A PMC paper on food challenge methodology confirmed it as the reference standard for diagnosing food allergy — the closest thing to proof the field has.
Why it is almost never done in practice
It is time-consuming, requires clinical supervision, carries a small risk of triggering a reaction, and demands careful preparation of disguised food vehicles. In a healthcare system not resourced for this kind of intensive diagnostic work, it simply does not happen outside specialist allergy centres. The result is a diagnostic gap that commercial tests have rushed to fill — not with validated alternatives, but with assays that measure something, just not necessarily the right thing. A review on the diagnosis and management of food allergies confirmed that misdiagnosis — including over-diagnosis from unvalidated tests — carries real clinical risk, not just inconvenience.
What This Means If You Are Symptomatic But Undiagnosed
The real cost of a false positive — unnecessary elimination and nutritional risk
When an IgG panel returns thirty “reactive” foods and you begin eliminating them, the downstream consequences are not trivial. You may cut out entire food groups. Your diet narrows. If you eliminate dairy, gluten, eggs, and legumes simultaneously — a common outcome of broad sensitivity panels — you are removing major sources of protein, calcium, fibre, and B vitamins without confirmed clinical justification. A 2025 publication confirmed that food allergy carries far-reaching impacts on nutrition and psychological health — but so does unnecessary food restriction. The anxiety of avoiding foods, the social friction, the nutritional gaps: these are real costs attached to a diagnosis that may not be accurate.
This is precisely the kind of question that a routine annual check-up was not designed to answer — not because clinicians do not care, but because population-level reference ranges and standard panels were never built to decode an individual’s pattern of delayed, multi-system, food-related symptoms. A ten-minute appointment cannot do what this diagnostic question actually requires.
What a useful diagnostic pathway actually looks like
The most useful approach begins not with a test, but with a structured symptom history. Onset timing matters enormously. A reaction that appears within fifteen minutes of eating points toward IgE-mediated allergy. A reaction that builds over hours or days, varies in severity, and tracks inconsistently with the suspected food is a different problem requiring a different tool. A supervised elimination diet — removing a specific suspected food for a defined period and then reintroducing it under observation — remains one of the most clinically useful approaches when conducted with proper guidance. It is not glamorous, it does not come in a kit, and it requires patience. But it generates real signal. An IgG panel generates noise that looks like signal.
One Thing to Do With This Research
Before your next GP or specialist visit, note the specific pattern of your symptoms — onset timing after eating (minutes vs hours vs days), whether they are consistent with the same food every time, and whether they involve immune-type reactions (hives, swelling, breathing changes) or digestive ones (bloating, discomfort, loose stools). Then ask your doctor one direct question: “Based on my symptom pattern, which diagnostic pathway — IgE skin prick or blood test, elimination diet, or food challenge — is actually appropriate for what I am describing?” If your current “food sensitivity panel” is IgG-based, bring that up specifically. The research suggests your next step should be guided by symptom type, not by which test is most available online.
